Vital Signs with Jacob Effron and Nikhil Krishnan

Ep 25: Dotmatics CEO Thomas Swalla on The State of R&D Software

Episode Summary

Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences.

Episode Notes

Jacob and Nikhil sit down with Dotmatics CEO Thomas Swalla to discuss R&D software, differences in software requirements across biotechs, growing through 11 acquisitions and expanding beyond life sciences. 

 

0:00 intro

0:36 getting into healthcare

5:20 what R&D looks like today

8:03 what does Dotmatics do?

13:06 differences in software requirements across biotechs

20:15 bundling vs. “best-of-breed”

23:46 do life sciences need their own data tools?

26:44 incorporating AI into Dotmatics tools

34:38 AI replacing scientists

37:39 how Dotmatics tools can serve companies outside of life sciences

39:50 acquisition strategy

44:43 spaces for innovation in R&D